The cannabis sector has been booming in Switzerland since 2016 when the country legalized cannabis flowers containing less than 1% THC as a tobacco substitute. Along with the production, further processing and trading of CBD, the production and export of medical cannabis containing over 1% THC will be permitted from the middle of 2022. Pilot projects are also underway relating to the authorization of cannabis for leisure use and experts are predicting that comprehensive regulation will be achieved within the next three years.
As an addition to theCB Expo (Cannabis Business Expo & Conference) and CannaTrade (business and consumer trade fair), the CB Club is offering a select group the chance to acquire news, insight and new contacts within a refined setting and relaxed atmosphere at one-day networking events.
14 April 2022
23 September 2020
Production facilities > Building Regulations
Marc Montandon, CarbonActive GmbH
Law & Order > CBD Legal Position (Novel Food, Therapeutic Products)
Lawyer Marcel Boller, Wenger & Vieli AG
Law & Order > Growing and Export of THC – Current legal situation in Switzerland
Dr. Christian Werz, Bundesamt für Gesundheit (BAG)
Law & Order > Quality Management for Cannabis businesses
Stefan Martin Meyer, PhytoFlow
Trading > Cannabis Stock Market, Market Place
Ben Arn, CannaTrade.ch AG
This website applies cookies to grant you the best possible service. By using this website you accept the insert of cookies. By using this website you accept the insert of cookies. Further information on our data privacy statement you will find here.
10-11 Sept, 2022